Early glucose abnormalities revealed by continuous glucose monitoring associate with lung function decline in cystic fibrosis: A five-year prospective study.

MLA

Rakotoarisoa, Luc, et al. “Early Glucose Abnormalities Revealed by Continuous Glucose Monitoring Associate with Lung Function Decline in Cystic Fibrosis: A Five-Year Prospective Study.” Journal of Diabetes and Its Complications, vol. 38, no. 4, Apr. 2024, p. 108703. EBSCOhost, https://doi.org/10.1016/j.jdiacomp.2024.108703.

APA

Rakotoarisoa, L., Weiss, L., Lefebvre, F., Porzio, M., Renaud-Picard, B., Ravoninjatovo, B., Abely, M., Danner-Boucher, I., Dubois, S., Troussier, F., Prevotat, A., Rault, G., Kessler, R., & Kessler, L. (2024). Early glucose abnormalities revealed by continuous glucose monitoring associate with lung function decline in cystic fibrosis: A five-year prospective study. Journal of Diabetes and Its Complications, 38(4), 108703. https://doi.org/10.1016/j.jdiacomp.2024.108703

Chicago

Rakotoarisoa, Luc, Laurence Weiss, François Lefebvre, Michele Porzio, Benjamin Renaud-Picard, Bruno Ravoninjatovo, Michel Abely, et al. 2024. “Early Glucose Abnormalities Revealed by Continuous Glucose Monitoring Associate with Lung Function Decline in Cystic Fibrosis: A Five-Year Prospective Study.” Journal of Diabetes and Its Complications 38 (4): 108703. doi:10.1016/j.jdiacomp.2024.108703.